De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Apiam Animal Health Beheer

Beheer criteriumcontroles 3/4

De CEO Apiam Animal Health's is Chris Richards, benoemd in Nov2015, heeft een ambtstermijn van 8.92 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 595.67K, bestaande uit 72.5% salaris en 27.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 22.45% van de aandelen van het bedrijf, ter waarde A$ 18.33M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.9 jaar en 8.9 jaar.

Belangrijke informatie

Chris Richards

Algemeen directeur

AU$595.7k

Totale compensatie

Percentage CEO-salaris	72.5%
Dienstverband CEO	8.9yrs
Eigendom CEO	22.4%
Management gemiddelde ambtstermijn	3.9yrs
Gemiddelde ambtstermijn bestuur	8.9yrs

Recente managementupdates

Recent updates

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

Aug 08

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Feb 24

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

Oct 12

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Sep 02

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Feb 28

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

Nov 18

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Mar 12

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

Feb 25

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Feb 08

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jan 18

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

Dec 28

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

Dec 11

Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?

Nov 24

Analyse CEO-vergoeding

Hoe is Chris Richards's beloning veranderd ten opzichte van Apiam Animal Health's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	AU$5m
Mar 31 2024	n/a	n/a	AU$4m
Dec 31 2023	n/a	n/a	AU$3m
Sep 30 2023	n/a	n/a	AU$2m
Jun 30 2023	AU$596k	AU$432k	AU$2m
Mar 31 2023	n/a	n/a	AU$4m
Dec 31 2022	n/a	n/a	AU$6m
Sep 30 2022	n/a	n/a	AU$5m
Jun 30 2022	AU$505k	AU$368k	AU$5m
Mar 31 2022	n/a	n/a	AU$4m
Dec 31 2021	n/a	n/a	AU$4m
Sep 30 2021	n/a	n/a	AU$5m
Jun 30 2021	AU$455k	AU$361k	AU$5m
Mar 31 2021	n/a	n/a	AU$5m
Dec 31 2020	n/a	n/a	AU$5m
Sep 30 2020	n/a	n/a	AU$5m
Jun 30 2020	AU$401k	AU$355k	AU$4m
Mar 31 2020	n/a	n/a	AU$4m
Dec 31 2019	n/a	n/a	AU$3m
Sep 30 2019	n/a	n/a	AU$3m
Jun 30 2019	AU$389k	AU$350k	AU$3m
Mar 31 2019	n/a	n/a	AU$3m
Dec 31 2018	n/a	n/a	AU$3m
Sep 30 2018	n/a	n/a	AU$3m
Jun 30 2018	AU$396k	AU$350k	AU$3m

Compensatie versus markt: De totale vergoeding ($USD 411.09K ) Chris } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 313.13K ).

Compensatie versus inkomsten: De vergoeding van Chris is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Chris Richards

8.9yrs

Tenure

AU$595,673

Compensatie

Dr. Christopher Irwin Richards, also known as Chris, BSc, BVSc, MAICD, has been Managing Director of Apiam Animal Health Limited since November 1, 2015. Dr. Richards founded Chris Richards & Associates in...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Christopher Richards	MD & Executive Director	8.9yrs	AU$595.67k	22.45% A$ 17.9m
Matthew White	Chief Financial Officer	no data	AU$347.51k	0.25% A$ 203.2k
Renee Waters	Chief People Officer	no data	AU$258.44k	0.093% A$ 74.3k
Duncan Runciman	Chief Veterinary Officer	less than a year	geen gegevens	0.61% A$ 484.5k
Eryl Baron	Company Secretary	3.9yrs	geen gegevens	geen gegevens

3.9yrs

Gemiddelde duur

Ervaren management: Het managementteam van AHX wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.9 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Christopher Richards	MD & Executive Director	9.6yrs	AU$595.67k	22.45% A$ 17.9m
Andrew Vizard	Independent Non-Executive Chairman	8.9yrs	AU$140.00k	0.19% A$ 152.3k
Evonne Collier	Independent Non-Executive Director	2yrs	AU$52.50k	geen gegevens
Richard Dennis	Independent Non-Executive Director	8.9yrs	AU$80.00k	0.0069% A$ 5.5k
Jan Tennent	Independent Non-Executive Director	6.2yrs	AU$70.00k	0.069% A$ 55.3k

8.9yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van AHX wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.9 jaar).

Apiam Animal Health Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

MD & Executive Director recently bought AU$596k worth of stock

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

MD & Executive Director recently bought AU$134k worth of stock

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: AU$0.028 (vs AU$0.013 in FY 2023)

Apiam Animal Health Limited to Report Fiscal Year 2024 Results on Aug 23, 2024

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

MD & Executive Director recently bought AU$596k worth of stock

Upcoming dividend of AU$0.01 per share

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

MD & Executive Director recently bought AU$134k worth of stock

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Financial data availability

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

Consensus EPS estimates fall by 17%

Price target decreased by 8.0% to AU$0.86

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Apiam Animal Health Limited (ASX:AHX) acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harradine and Associates for AUD 2.6 million.

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Price target increased to AU$1.13

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Apiam Animal Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Consensus forecasts updated

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire assets of Victorian Equine Group and Romsey Veterinary Surgery for AUD 13.75 million.

Insufficient new directors

Upcoming dividend of AU$0.012 per share

Consensus forecasts updated

First half 2022 earnings: EPS misses analyst expectations

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Period Ended December 31, 2021, Payable on April 20, 2022

Apiam Animal Health Limited to Report First Half, 2022 Results on Feb 25, 2022

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Fraser Coast Veterinary Services.

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

MD & Executive Director recently bought AU$96k worth of stock

Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Harbour City Veterinary Surgery.

Insufficient new directors

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Full year 2021 earnings released: EPS AU$0.042 (vs AU$0.037 in FY 2020)

Price target increased to AU$0.85

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harbour City Veterinary Surgery for AUD 2.8 million.

Apiam Animal Health Limited (ASX: AHX) acquired Assets of Golden Plains Animal Hospital.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire The Scenic Rim for AUD 16 million.

A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Samford Valley Veterinary Hospital.

Apiam Animal Health Limited (ASX:AHX) acquired Clermont Veterinary Surgery.

MD & Executive Director recently bought AU$252k worth of stock

With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting

Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Upcoming Dividend of AU$0.012 Per Share

New 90-day high: AU$0.74

Analysts update estimates

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

First half 2021 earnings released: EPS AU$0.022 (vs AU$0.015 in 1H 2020)

Apiam Animal Health Limited to Report First Half, 2021 Results on Feb 24, 2021

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

New 90-day low: AU$0.57

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

New 90-day low: AU$0.60

Price target lowered to AU$0.59

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

New 90-day high: AU$0.74

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Crosvet Pty Ltd.